Abstract: The present invention relates to antigenic and vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to a process for the production of both monovalent and multivalent VLPs, the VLPs comprising capsid proteins from one or more Norovirus genogroups.
Type:
Application
Filed:
June 16, 2010
Publication date:
June 21, 2012
Applicant:
LigoCyte Pharmaceutical
Inventors:
Charles RICHARDSON, Thomas S. Vedvick, Thomas R. Foubert, William T. Tino